Pfizer Vancomycin Hydrochloride 750mg Injection Recall: Glass Particulate Hazard
Pfizer recalls Vancomycin Hydrochloride 750mg sterile powder for injection due to glass particles in vials. This poses a risk of serious injury during medical use. Affected products include specific lots from Hospira.
Use caution until it’s fixed
Presence of Particulate Matter: glass particulate found in vial
Contact the company
What happened, in plain English
Pfizer has recalled Vancomycin Hydrochloride 750mg sterile powder for injection because glass particles were found in the vials. This could cause serious injury if the medication is administered improperly. Read more at govinfonow.com/recall/41288-pfizer-vancomycin-hydrochloride-750mg-injection-recall-glass-particulate-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/41288-pfizer-vancomycin-hydrochloride-750mg-injection-recall-glass-particulate-hazard · Updated October 7, 2026 · FDA enforcement record: FDA #D-0123-2018
Cite this page
“Pfizer Vancomycin Hydrochloride 750mg Injection Recall: Glass Particulate Hazard.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41288-pfizer-vancomycin-hydrochloride-750mg-injection-recall-glass-particulate-hazard. Based on FDA recall #D-0123-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0123-2018%22&limit=1).
Why it’s dangerous
Glass particles in the vials could become lodged in the bloodstream or tissues during injection, potentially causing serious injury or infection. This hazard occurs when the medication is administered to patients.
Who’s affected
Healthcare professionals using this medication for medical treatment are most at risk. Patients receiving the medication through a hospital or clinic are affected.
How to tell if you have this one
Check for the product name 'Vancomycin Hydrochloride for Injection, USP 750 mg Sterile Powder' with NDC code 0409-6531-02 and lot number 632153A. The expiration date is March 2018.
- Brand
Pfizer- Category
Drug
What to do — step by step
Check Product Details
Verify the NDC code 0409-6531-02 and lot number 632153A on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0123-2018 (August 30, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0123-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.